Functional analysis of hypertrophic cardiomyopathy missense mutations in the light meromyosin region of beta myosin heavy chain

Functional analysis of hypertrophic cardiomyopathy missense mutations in the light meromyosin region of beta myosin heavy chain

Bibliographic Details
Main Authors:	Redwood, C, Flashman, E, Blair, E, Watkins, H
Format:	Conference item
Published:	2003

Similar Items

Mutations of the light meromyosin domain of the beta-myosin heavy chain rod in hypertrophic cardiomyopathy.
by: Blair, E, et al.
Published: (2002)

Identification of novel interactions between domains of Myosin binding protein-C that are modulated by hypertrophic cardiomyopathy missense mutations.
by: Moolman-Smook, J, et al.
Published: (2002)

Mutation in the beta-myosin heavy chain (β-MHC) gene of adult Bangladeshi patients with hypertrophic cardiomyopathy
by: Laila Anjuman Banu, et al.
Published: (2023-02-01)

Mutation in the beta-myosin heavy chain (β-MHC) gene of adult Bangladeshi patients with hypertrophic cardiomyopathy
by: Laila Anjuman Banu, et al.
Published: (2023-02-01)

Mutation in the beta-myosin heavy chain (β-MHC) gene of adult Bangladeshi patients with hypertrophic cardiomyopathy
by: Laila Anjuman Banu, et al.
Published: (2023-02-01)

Hypertrophic cardiomyopathy mutations in MYBPC3 dysregulate myosin
by: Toepfer, C, et al.
Published: (2019)

Myosin Heavy Chain Converter Domain Mutations Drive Early-Stage Changes in Extracellular Matrix Dynamics in Hypertrophic Cardiomyopathy
by: Jeanne Hsieh, et al.
Published: (2022-06-01)

Beta-Myosin Heavy Chain (β-MHC) and Myosin Binding Protein C (MyBP-C) genes mutation in Bangladeshi hypertrophic Cardiomyopathy Patients: a genotype-phenotype correlation
by: Laila Anjuman Banu, et al.
Published: (2017-12-01)

Direct evidence in man for haploinsufficiency as the mechanism of action of myosin-binding protein C mutations that cause hypertrophic cardiomyopathy
by: Carballo, S, et al.
Published: (2008)

Ascertainment strategies and genotype:phenotype correlations in hypertrophic cardiomyopathy.
by: Blair, E, et al.
Published: (2003)

Localization of the binding site of the C-terminal domain of cardiac myosin-binding protein-C on the myosin rod.
by: Flashman, E, et al.
Published: (2007)

Crystal structure of the C1 domain of cardiac myosin binding protein-C: implications for hypertrophic cardiomyopathy.
by: Govada, L, et al.
Published: (2008)

Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.
by: Ashrafian, H, et al.
Published: (2003)

Hypertrophic cardiomyopathy mutations in the pliant and light chain-binding regions of the lever arm of human β-cardiac myosin have divergent effects on myosin function
by: Makenna M Morck, et al.
Published: (2022-06-01)

Interaction analyses elucidate the pathophysiology of HCM-causing missense mutations in cardiac myosin binding protein-C.
by: Moolman-Smook, J, et al.
Published: (2001)

Early onset malignant hypertrophic cardiomyopathy caused by mutations in MYBPC3
by: Carballo, S, et al.
Published: (2003)

Investigation of troponin I mutations causing familial hypertrophic cardiomyopathy
by: Abdulrazzak, H, et al.
Published: (2001)

Novel mutations in cardiac MYBPC3 and early onset malignant hypertrophic cardiomyopathy
by: Carballo, S, et al.
Published: (2005)

Acceleration of the sliding movement of actin filaments with the use of a non-motile mutant myosin in in vitro motility assays driven by skeletal muscle heavy meromyosin.
by: Kohei Iwase, et al.
Published: (2017-01-01)

Novel mutations in cardiac MYBPC3 causing early onset malignant hypertrophic cardiomyopathy
by: Carballo, S, et al.
Published: (2005)

Effects of hypertrophic cardiomyopathy mutations in troponin I on contractility of skinned cardiac muscle fibres
by: Burton, D, et al.
Published: (2002)

Double mutations in CIS can confound genotype-phenotype correlations in hypertrophic cardiomyopathy
by: Blair, E, et al.
Published: (2000)

Cardiac myosin binding protein C: its role in physiology and disease.
by: Flashman, E, et al.
Published: (2004)

Hypertrophic cardiomyopathy in myosin-binding protein C (MYBPC3) Icelandic founder mutation carriers
by: Javier Diez, et al.
Published: (2020-06-01)

Mutations in cis can confound genotype-phenotype correlations in hypertrophic cardiomyopathy.
by: Blair, E, et al.
Published: (2001)

Myosins and MyomiR Network in Patients with Obstructive Hypertrophic Cardiomyopathy
by: Chiara Foglieni, et al.
Published: (2022-09-01)

Novel mutations in cardiac MYPBC3 cause early onset malignant hypertrophic cardiomyopathy (HCM)
by: Carballo, S, et al.
Published: (2005)

Commentary: Effect of Skeletal Muscle Native Tropomyosin on the Interaction of Amoeba Actin with Heavy Meromyosin
by: Joseph Michael Chalovich, et al.
Published: (2016-08-01)

Comparison of the functional effects of mutations in troponin T which cause dilated and hypertrophic cardiomyopathies
by: Robinson, P, et al.
Published: (2002)

β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity
by: Arjun S. Adhikari, et al.
Published: (2019-06-01)

Hypertrophic cardiomyopathy mutations in the gamma 2 subunit of AMP-activated kinase suggest a central role of energy compromise in disease pathogenesis
by: Blair, E, et al.
Published: (2001)

Myosin sequestration regulates sarcomere function, cardiomyocyte energetics, and metabolism, informing the pathogenesis of hypertrophic cardiomyopathy
by: Toepfer, CN, et al.
Published: (2020)

Development of induced pluripotent stem cells from a patient with hypertrophic cardiomyopathy who carries the pathogenic myosin heavy chain 7 mutation p.Arg403Gln
by: Mira Holliday, et al.
Published: (2018-12-01)

Dilated cardiomyopathy mutation (R134W) in mouse cardiac troponin T induces greater contractile deficits against α-myosin heavy chain than against β-myosin heavy chain
by: Sampath K Gollapudi, et al.
Published: (2016-10-01)

X-ray solution scattering of squid heavy meromyosin: strengthening the evidence for an ancient compact off state.
by: Richard E Gillilan, et al.
Published: (2013-01-01)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
by: Hudsmith, L, et al.
Published: (2006)

A novel interaction between the C5 and C8 domains of myosin binding protein-C and its modulation by HCM mutations
by: Flashman, E, et al.
Published: (2002)

A novel mutation in phospholamban causes a mixed hypertrophic and dilated cardiomyopathy phenotype with autosomal dominant inheritance
by: Carballo, S, et al.
Published: (2004)

The R403Q myosin mutation implicated in familial hypertrophic cardiomyopathy causes disorder at the actomyosin interface.
by: Niels Volkmann, et al.
Published: (2007-11-01)

Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy
by: Maneiro Emilia, et al.
Published: (2010-04-01)